Businesses can now set science-based targets covering ocean and maritime protection, under the latest guidance introduced by ...
GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback